APIS · Notes

Treatment Delay and Cancer Progression

Timing can matter in cancer care. How much a delay matters depends on the cancer type, stage, symptoms and the planned treatment, so the question belongs with the treating team.

What the Evidence Shows

A 2020 systematic review and meta-analysis in The BMJ pooled observational studies on seven cancers. Each four-week delay in starting treatment was associated with higher mortality for many indications, including surgery (hazard ratio about 1.06 to 1.08) and selected systemic and radiation treatments. [1]

All included studies were retrospective, so the results show association, not proof that a given delay caused harm in an individual patient. Some delays are medically acceptable; others may narrow the options that remain.

When Waiting Needs Closer Review

  • The disease is progressing or symptoms are getting worse.
  • The cancer has come back or is locally advanced.
  • Treatment options are already limited.
  • The planned treatment is time-sensitive, or eligibility could change with further delay.

Questions for Your Treating Team

  • How long is it medically reasonable to wait in my situation?
  • Could waiting change the plan or my eligibility for the recommended treatment?
  • What is the next step if treatment cannot begin within that time?

If treatment is delayed for insurance or capacity reasons, a separate hospital review can run in parallel and clarify whether another clinically appropriate option could begin in time.

Check Whether Another Option Could Start Sooner

Share your diagnosis and the expected start date of your current plan.

Sources and dates
  1. Hanna TP et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 2020;371:m4087. Published November 4, 2020.

Content reviewed November 17, 2026.

Your request has been received.
We will review the submitted information and contact you by email if additional details are required.​